Recursion Pharmaceuticals Inc.
RXRX | NASDAQ
$4.05
+$0.08 (+2.02%)
Sep 22, 2026, 1:02 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -248.51M | -117.5M | -108.12M | -162.25M | -171.9M | -202.49M | -178.91M | -95.84M | -97.54M | -91.37M | -93M | -93.02M | -76.73M | -65.33M | -57.49M | -60.45M | -65.56M | -55.98M | -64.93M | -47.43M | -43.4M | -30.72M |
Depreciation & Amortization | 37.84M | 19.67M | 19.48M | 21.04M | 23.85M | 19.33M | 12.95M | 7.2M | 8.97M | 7.38M | 7.55M | 7.58M | 5.54M | 3.73M | 3.21M | 2.99M | 2.79M | 2.77M | 2.24M | 2.44M | 2.33M | 1.4M |
Stock-Based Compensation | 41.71M | 22.22M | 23.76M | 25.24M | 26.16M | 36.06M | 30.78M | 18.25M | 16.52M | 16.13M | 16.09M | 16.79M | 11.81M | 8.81M | 7.7M | 8.91M | 5.68M | 5.63M | 4.34M | 3.36M | 5.32M | 1.82M |
Other Working Capital | -14.35M | -24.62M | 7.1M | -23.94M | 14.58M | -14.38M | 2.75M | 2.19M | -6.73M | -36.58M | -4.53M | -6.45M | -6.79M | -23.75M | -6.87M | -12.26M | -465K | 122.75M | -1.82M | 8.54M | 454K | -3.85M |
Other Non-Cash Items | 6.46M | 6.92M | 8.13M | 24.9M | 10.32M | 20.99M | 13.69M | 11.43M | -2.84M | 2.02M | 6.55M | 189K | 2.03M | 3.87M | 2.44M | 1.77M | 5.01M | 2.14M | 1.16M | 1.29M | 1.11M | 1.37M |
Deferred Income Tax | -4.6M | -4.6M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -19.95M | -7.81M | 10.68M | -26.3M | 35.15M | -5.85M | 6.05M | -264K | -7.33M | -36.45M | -11.27M | -4.46M | -10.12M | -24.4M | -601K | -7.77M | -9.54M | 122.82M | -3.96M | 7.29M | 993K | -4.63M |
Operating Cash Flow | -187.05M | -81.1M | -46.07M | -117.36M | -76.42M | -131.96M | -115.43M | -59.23M | -82.22M | -102.3M | -74.08M | -72.92M | -67.47M | -73.32M | -44.75M | -54.54M | -61.62M | 77.39M | -61.16M | -33.05M | -33.65M | -30.76M |
Capital Expenditures | -302K | -258K | -1.24M | -243K | -3.15M | -1.83M | -1.65M | -4.56M | -4.18M | -6.65M | -2.42M | -827K | -3.97M | -5.34M | -7.98M | -8.56M | -16.48M | -4.34M | -4.46M | -9.71M | -6.21M | -19.42M |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | -4.44M | 277.1M | n/a | n/a | n/a | -71K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | -2.31M | -500K | -1M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -116.97M | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 480K | n/a | n/a | n/a | 61.55M | 21.42M | 147.65M | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -2M | n/a | n/a | n/a | -2.16M | n/a | -350K | n/a | -3M | n/a | -350K | -82K | 1.92M | -165K | n/a | -300K | n/a | n/a | 69.19M | -184.17M | n/a | n/a |
Investing Cash Flow | -2.3M | -338K | -1.24M | -2.55M | -5.81M | -7.27M | 275.46M | -4.56M | -4.18M | -6.65M | -2.49M | -347K | -2.05M | -5.34M | -7.98M | 52.98M | 4.94M | 143.3M | -52.24M | -193.87M | -6.21M | -19.42M |
Debt Repayment | -4.46M | -2.21M | -2.17M | -2.13M | -2.08M | -2.05M | -2.1M | -2.29M | -26K | -26K | -694K | -24K | -24K | -24K | -23K | -23K | -22K | -22K | -21K | -12.74M | -20K | -20K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -278K | n/a | n/a | -993K | -3M | 1.55M | 1.71M | 1.78M | 1.6M | 3.05M | 3.26M | 3.79M | n/a | n/a | 3.57M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Financial Cash Flow | -4.74M | -3.47M | 132.01M | 251.34M | 97.66M | 40.53M | 10.64M | 16.46M | 263.12M | 13.9M | 80.66M | 53.77M | 3.79M | 1.92M | 147.26M | 2.34M | 2.67M | 2.08M | 3.8M | -11.1M | 463.71M | 2.13M |
Net Cash Flow | -197.1M | -87.9M | 86.78M | 133.3M | 24.69M | -93.87M | 167.19M | -46.92M | 176.6M | -95.28M | 4.22M | -19.62M | -65.55M | -76.74M | 94.46M | 960K | -53.64M | 222.74M | -118.29M | -238.02M | 423.84M | -48.04M |
Free Cash Flow | -187.35M | -81.36M | -47.32M | -117.6M | -79.57M | -133.79M | -117.08M | -63.79M | -86.4M | -108.95M | -76.49M | -73.75M | -71.44M | -78.66M | -52.73M | -63.1M | -78.1M | 73.05M | -65.62M | -42.75M | -39.87M | -50.17M |
Adj. Free Cash Flow | -229.06M | -103.57M | -71.08M | -142.85M | -105.73M | -169.85M | -147.86M | -82.04M | -102.93M | -125.08M | -92.58M | -90.54M | -83.25M | -87.47M | -60.42M | -72.01M | -83.77M | 67.41M | -69.96M | -46.12M | -45.18M | -51.99M |
Maintenance CapEx | -302K | -258K | n/a | -243K | n/a | n/a | -1.65M | n/a | n/a | -1.57M | -2.42M | -827K | n/a | n/a | n/a | n/a | n/a | n/a | -4.46M | n/a | n/a | -396.23K |
Growth CapEx | n/a | n/a | -1.24M | n/a | -3.15M | -1.83M | n/a | -4.56M | -4.18M | -5.08M | n/a | n/a | -3.97M | -5.34M | -7.98M | -8.56M | -16.48M | -4.34M | n/a | -9.71M | -6.21M | -19.02M |
Owner Earnings | -187.35M | -81.36M | -46.07M | -117.6M | -76.42M | -131.96M | -117.08M | -59.23M | -82.22M | -103.87M | -76.49M | -73.75M | -67.47M | -73.32M | -44.75M | -54.54M | -61.62M | 77.39M | -65.62M | -33.05M | -33.65M | -31.15M |
Add to Watchlist
Select watchlists to add or remove RXRX